Business Wire

How Dahua Technology Helps Prevent Forest Fires

18.5.2021 16:45:00 EEST | Business Wire | Press release

Share

It takes decades for trees to grow, yet only minutes for fires to destroy them. Forest fires are the type of natural disaster that strike with sudden destructiveness and are often difficult to control. That’s why working to prevent forest fires and the damage they cause to natural resources — as well as people’s property and sometimes human life — is a priority for Dahua Technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005588/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Dahua Solution Safeguarding The Yarlung Zangbo Grand Canyon (Photo: Business Wire)

Over the years, Dahua Technology has developed and deployed capabilities for comprehensive technical support in forest and grassland fire monitoring as well as early warning, forecasting, rescue and post-disaster assessment with digital intelligence technology. Dahua’s technology fully integrates video perception systems with integrated sky and ground monitoring methods to form a strong "fire net" aimed at prevention and early, decisive intervention when needed.

The Yarlung Zangbo Grand Canyon is the largest and deepest canyon on earth. The terrain of the canyon forest area is complex, steep and deep, with precious and diverse vegetation ecological resources, and is very difficult to protect. Dahua Technology helped build a smart forest fire prevention monitoring system, safeguarding forests through digital technology. Based on thermal imaging technology, the system provides 360° long-distance monitoring and uninterrupted 7/24 protection, guarding the vast forests and lush mountains.

In Chibi City, Hubei, Dahua Technology built an integrated forest fire prevention system for Guantangyi Forest Farm. The system uses dual-spectral thermal imaging to detect fires in real time, links video feeds to command centers, and connects alarms on fire ranger’s handheld devices, through to a six-rotor UAV that monitors the situation from above. The seamless flow of information through this system enables forest rangers to rush to a target area with a patrol terminal in hand to conduct on-site command, fire search and rescue, and other first responder functions.

It takes integrated capabilities working together to save forests, and Dahua solutions make it possible. Dahua employees take special pride in being able to contribute to this mission; for example, “When I walked through many forested areas in the country, every time I was not only emotional, but also felt responsible. Dahua Technology has always been involved in forest fire prevention. In the future, the company will continue to use technology to protect the ecology and intelligence to guard a green future.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Vivid Gu
18969121820
PR_Global@dahuatech.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye